Navigation Links
West Haven Firm Expands Biomedical Disposal Program with Community Economic Development Fund

MERIDEN, Conn., May 14 /PRNewswire/ -- Connecticut waterways may be safer from biomedical waste, thanks to an innovative Community Economic Development Fund small business loan guarantee program. CEDF, with loan-program partners, Connecticut's Department of Economic and Community and the City of West Haven have guaranteed a small business loan to a West Haven company that stems improper disposal of needles and prescription drugs.

West Haven's Pathacura removes area medical waste from health care facilities safely and with a dedication to protecting one of the state's most precious assets, its water. "Pharmaceuticals and personal health care products in the water are a growing national concern; it's important that Connecticut's water is protected from pollutants and chemicals," says Pathacura's Michael Monsillo.

Monsillo's father started Pathacura 15 years ago. The son's been growing the business despite difficult economic conditions. Even as the recession deepened, Pathacura's volume spiked with H1N1 testing and vaccinations. "Pathacura's credit needed development, but we were too small a company to go to a bank for funding," he says.

Monsillo heard about CEDF's micro-finance loan guarantee program at a Rotary Club meeting. CEDF, with the Department of Economic and Community Development and cities of Hartford, Stamford, Bridgeport and West Haven, created the program to mitigate the risk of eligible small businesses. The cities support the small loans with 30 percent guarantees. The program is also partially funded by the Small Business Administration.

Pathacura is using the loan to expand its medical hazardous remediation work for local businesses and public facilities.

"The guarantee programs with our partners enhance CEDF's ability to support small business, particularly start-up or at-risk business and those with little or no collateral," says Donna Wertenbach, CEDF President and CEO. She noted that CEDF can make these loans because 21 banks and other institutions have invested in CEDF's small business, high-risk loan pool.

CEDF was created in 1994 to revitalize Connecticut's distressed neighborhoods by providing greater access to capital, technical assistance to small businesses and support for community economic development. Since then CEDF has provided millions of dollars in loans to small businesses, created and retained thousands of jobs for the state's residents, and funded numerous community planning efforts. Joining forces with the state, leading lenders and representatives from low and moderate income communities, CEDF is helping Connecticut's small businesses and neighborhoods.

Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Biodel Inc. Expands Ongoing Phase III VIAject(TM) Clinical Trials Into Europe
2. BiPar Expands Management Team to Advance Lead PARP Inhibitor Product Candidate Into Phase 2 Trials for Cancer
3. Cellectar Expands Clinical Management Team
4. VIA Pharmaceuticals Expands Clinical Trial Program for VIA-2291 in Acute Coronary Syndrome
5. PAREXEL Expands Late Phase Clinical Research Services and Appoints Leading Pharmacoepidemiology Expert Victor Kiri
6. Millennium Expands VELCADE(R) (Bortezomib) For Injection Program In Non-Hodgkins Lymphoma
7. PAREXEL Expands Global Clinical Pharmacology Capabilities
8. BiPar Sciences Expands Clinical Program for BSI-201, a Novel DNA Repair Inhibitor, in Brain Cancer
9. Senesco Expands on Recently Announced Preclinical Pancreatic Islet Data
10. Alseres Pharmaceuticals Expands Sites for the First Stage of the ALTROPANE(R) Phase III Clinical Trial Program
11. Delcath Expands Phase III Trial for Metastatic Melanoma to Include University of Maryland Medical Center
Post Your Comments:
(Date:10/13/2015)...  Graduate students across the country, with an ... soon have the opportunity to learn about a ... discovery and development process. Eli Lilly and Company ... leaders from academic institutions to create an elective ... Drug Development."  Lilly will formally unveil the eLearning ...
(Date:10/13/2015)... SAN FRANCISCO , October 13, 2015 ... expected to reach USD 26.8 billion by 2022, according ... Anesthesia and respiratory devices, owing to their capability to ... expected to witness a substantial growth. --> ... reach USD 26.8 billion by 2022, according to a ...
(Date:10/13/2015)... , Oct. 13, 2015   Micell Technologies ... DESSOLVE I and II trials of its MiStent Sirolimus ... ® ) were presented at the 27th Annual ... San Francisco , October 11-15. TCT ... cardiovascular medicine. MiStent SES was designed to optimize vessel ...
Breaking Medicine Technology:
(Date:10/13/2015)... ... 13, 2015 , ... The Lymphoma Research Foundation (LRF) – ... serving the lymphoma community through a comprehensive series of education programs, outreach initiatives ... Commitment to Cure last night at the Mandarin Oriental in New York City. ...
(Date:10/13/2015)... ... October 13, 2015 , ... The documentary Pink & Blue: Colors ... Beverly Hills October 2 - 8, coinciding with National Hereditary Breast & Ovarian Cancer ... takes us through the lives of women - and men - who are dealing ...
(Date:10/13/2015)... ... October 13, 2015 , ... Purdue University ... the Life Sciences Initiative aimed at enhancing Purdue’s life sciences research and graduate ... True” capital campaign. , The investment will result in cohesive efforts across several ...
(Date:10/13/2015)... (PRWEB) , ... October 13, 2015 , ... ... enterprise focused on cancer patients, today announced a new partnership with the ... battling this rare type of non-Hodgkin’s lymphoma, their families and physicians. , ...
(Date:10/13/2015)... Diego, CA (PRWEB) , ... October 13, 2015 ... ... launch of its newest technology platform, ENGAGE, at HIMSS’s Patient Engagement Summit ... to end. , ENGAGE delivers innovative health programs and interventions via mobile devices ...
Breaking Medicine News(10 mins):